These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11516107)

  • 1. T cell activation following infection of primary follicle center lymphoma B cells with adenovirus encoding CD154.
    Cantwell MJ; Wierda WG; Lossos IS; Levy R; Kipps TJ
    Leukemia; 2001 Sep; 15(9):1451-7. PubMed ID: 11516107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CpG oligodeoxynucleotides enhance the capacity of adenovirus-mediated CD154 gene transfer to generate effective B-cell lymphoma vaccines.
    Rieger R; Kipps TJ
    Cancer Res; 2003 Jul; 63(14):4128-35. PubMed ID: 12874017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus transduction to effect CD40 signalling improves the immune stimulatory activity of myeloma cells.
    Bashey A; Cantwell MJ; Kipps TJ
    Br J Haematol; 2002 Aug; 118(2):506-13. PubMed ID: 12139739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of adenoviruses encoding CD40L or IL-2 against B cell lymphoma.
    Meziane el K; Bhattacharyya T; Armstrong AC; Qian C; Hawkins RE; Stern PL; Dermime S
    Int J Cancer; 2004 Oct; 111(6):910-20. PubMed ID: 15300803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells.
    Kato K; Cantwell MJ; Sharma S; Kipps TJ
    J Clin Invest; 1998 Mar; 101(5):1133-41. PubMed ID: 9486984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia.
    Wierda WG; Cantwell MJ; Woods SJ; Rassenti LZ; Prussak CE; Kipps TJ
    Blood; 2000 Nov; 96(9):2917-24. PubMed ID: 11049967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activation of cancer patient-derived dendritic cells by tumor cells genetically modified to express CD154.
    Loskog A; Tötterman TH; Böhle A; Brandau S
    Cancer Gene Ther; 2002 Oct; 9(10):846-53. PubMed ID: 12224026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic expression of CD40L and interleukin-2 induces an autologous antitumor immune response in patients with non-Hodgkin's lymphoma.
    Takahashi S; Yotnda P; Rousseau RF; Mei Z; Smith S; Rill D; Younes A; Brenner MK
    Cancer Gene Ther; 2001 May; 8(5):378-87. PubMed ID: 11477458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking B7 and CD40 co-stimulatory molecules decreases antiviral T cell activity.
    Vermeiren J; Ceuppens JL; Haegel-Kronenberger H; De Boer M; Boon L; Van Gool SW
    Clin Exp Immunol; 2004 Feb; 135(2):253-8. PubMed ID: 14738453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral injection of Ad-ISF35 (Chimeric CD154) breaks tolerance and induces lymphoma tumor regression.
    Urquiza M; Melo-Cardenas J; Aguillon R; Kipps TJ; Castro JE
    Hum Gene Ther; 2015 Jan; 26(1):14-25. PubMed ID: 25382101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the CD154-positive and CD40-positive cellular subsets required for pathogenesis in retrovirus-induced murine immunodeficiency.
    Green KA; Noelle RJ; Durell BG; Green WR
    J Virol; 2001 Apr; 75(8):3581-9. PubMed ID: 11264347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenetic therapy for B-cell malignancies.
    Kipps TJ; Chu P; Wierda WG
    Semin Oncol; 2000 Dec; 27(6 Suppl 12):104-9. PubMed ID: 11225994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic and tumor cell fusions transduced with adenovirus encoding CD40L eradicate B-cell lymphoma and induce a Th17-type response.
    Alvarez E; Moga E; Barquinero J; Sierra J; Briones J
    Gene Ther; 2010 Apr; 17(4):469-77. PubMed ID: 20010627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
    Pan Y; Luo B; Sozen H; Kalscheuer H; Blazar BR; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2003 Jul; 76(1):216-24. PubMed ID: 12865813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with a recombinant adenovirus encoding a lymphoma idiotype: induction of tumor-protective immunity and identification of an idiotype-specific T cell epitope.
    Armstrong AC; Dermime S; Allinson CG; Bhattacharyya T; Mulryan K; Gonzalez KR; Stern PL; Hawkins RE
    J Immunol; 2002 Apr; 168(8):3983-91. PubMed ID: 11937555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro analysis of CD40-CD154 and CD28-CD80/86 interactions in the primary T-cell response to allogeneic "nonprofessional" antigen presenting cells.
    Laning JC; Deluca JE; Isaacs And CM; Hardin-Young J
    Transplantation; 2001 May; 71(10):1467-74. PubMed ID: 11391237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective transduction of dendritic cells in human lymph nodes and superior induction of high-avidity melanoma-reactive cytotoxic T cells by a CD40-targeted adenovirus.
    Hangalapura BN; Oosterhoff D; Aggarwal S; Wijnands PG; van de Ven R; Santegoets SJ; van den Tol MP; Hooijberg E; Pereboev A; van den Eertwegh AJ; Curiel DT; Scheper RJ; de Gruijl TD
    J Immunother; 2010 Sep; 33(7):706-15. PubMed ID: 20664356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival.
    Gao W; Demirci G; Strom TB; Li XC
    Transplantation; 2003 Sep; 76(6):994-9. PubMed ID: 14508368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nuclear factor-kappaB inhibitor BAY11-7082 inhibits interactions between human endothelial cells, T cells, and monocytes.
    Zhu B; Liu Z; Wang P; Wu C; Xu H
    Transplant Proc; 2008 Oct; 40(8):2724-8. PubMed ID: 18929846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune thrombocytopenia: flow cytometric determination of platelet-associated CD154/CD40L and CD40 on peripheral blood T and B lymphocytes.
    Meabed MH; Taha GM; Mohamed SO; El-Hadidy KS
    Hematology; 2007 Aug; 12(4):301-7. PubMed ID: 17654056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.